Why Is Lexeo Therapeutics Stock Gaining Monday? - Lexeo Therapeutics (NASDAQ:LXEO)

Lexeo Therapeutics stock jumps as LX2006 pivotal trial moves forward, with SUNRISE-FA 2 enrollment set to begin in June 2026.

Raccontata dabenzinga.com